向诊断性心力衰竭诊所提交的八十岁人的特征:SHEAF注册表
Luke Thompson1, Fiona Carr2,3, Dominic Rogers2
1Care of the Elderly, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
Open heart
|April 25, 2024
概括
心力衰竭 (HF) 在八十岁的年轻人中正在上升,心力衰竭与保留喷射分数 (HFpEF) 变得越来越常见. 老年HF患者的治疗优化与NYHA类III和HF降低射出分数 (HFrEF) 相关.
科学领域:
- 心脏病学 心脏病学
- 老年病的医生 老年病的医生
- 临床医学 临床医学
背景情况:
- 老年人心力衰竭 (HF) 发病率正在增加,由于住院和死亡率高,这给医疗保健带来了重大挑战.
- 在这个人口群体中,治疗HF通常因副作用和多种并发症的存在而复杂化.
- 这项研究侧重于向专门的HF诊所呈现的八十岁人的临床特征.
研究的目的:
- 为了研究八十岁的临床特征的变化,我们在两个不同的时间段上参考了一个心力衰竭诊所.
- 在这个老年人群中确定与优化药理学HF干预相关的临床因素.
主要方法:
- 一项横截面研究分析了八十岁 (80-89岁) 的人的时间数据,这些人被转到一个高频率诊所.
- 收集的数据包括人口统计,HF表型,并发症,症状和治疗,使用千平方测试和多变量回归分析.
- 统计学意义被设定为p<0.05.05.
主要成果:
- 在第二个时期 (2021-2022年) 中,有571名八十岁的年轻人被转诊,HF患病率为68.48%.
- 保持喷射分数 (HFpEF) 的HF是最常见的表型,与第一期相比显著增加 (46.3%与29.2%,p<0.001).
- 虚弱,慢性病和缺血性心脏病也显著增加. 对于减少喷射分数 (HFrEF) 的HF患者,86.4%的人服用β-阻断剂,82.7%的人服用ACE抑制剂/ARB/RNAI.
结论:
- 在被转移到HF诊所的八十岁人群中,HF患病率仍然很高,HFpEF显著增加.
- 与优化HF药理疗法相关的临床特征包括NYHA功能类III和HFrEF表型.
- 在八十多岁的人中加强HF治疗的决定主要是根据NYHA类和喷射小部分状态来指导的.
相关概念视频
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Heart Failure Drugs: β-Blockers
337
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
337
Heart Failure Drugs: Inotropic Agents
574
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
574
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
422
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
422
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Assessment of the Cardiovascular System I: Subjective Data
322
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
322


